Filing Details

Accession Number:
Form Type:
Zero Holdings:
Publication Time:
2021-08-03 17:13:56
Reporting Period:
Accepted Time:
2021-08-03 17:13:56
SEC Url:
Form 4 Filing
Cik Name Symbol Sector (SIC) IRS No
1741830 Kronos Bio Inc. KRON Pharmaceutical Preparations (2834) 000000000
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1826766 Christopher Dinsmore C/o Kronos Bio, Inc.
1300 So. El Camino Real, Suite 300
San Mateo CA 94402
Chief Scientific Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2021-08-02 9,189 $3.27 105,549 No 4 M Direct
Common Stock Disposition 2021-08-02 9,189 $20.59 96,360 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Employee Stock Option (Right to Buy) Disposition 2021-08-02 9,189 $0.00 9,189 $3.27
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
333,686 2030-06-14 No 4 M Direct
  1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 17, 2021.
  2. The weighted average sale price for the transaction reported was $20.586, and the range of prices were between $20.23 and $21.08. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.
  3. Immediately exercisable.